V. Villagrasa et al., EFFECTS OF ERYTHROMYCIN ON CHEMOATTRACTANT-ACTIVATED HUMAN POLYMORPHONUCLEAR LEUKOCYTES, General pharmacology, 29(4), 1997, pp. 605-609
1. Erythromycin (2-100 mu g ml(-1)) produced a concentration-related i
nhibition of superoxide generation and elastase release induced by in
vitro exposure of human polymorphonuclear leukocytes (PMNs) to the che
motactic peptide N-formylmethionyl-leucyl-phenylalanine (FMLP; 30 nM).
2. By contrast, erythromycin (100 mu g ml(-1)) did not alter the leuk
otriene B-4 production elicited by FMLP (30 nM; in the presence of thi
merosal 20 mu M) or the intracellular calcium changes promoted by FMLP
(30 nM; in the absence or presence of thimerosal 20 mu M). 3. These r
esults indicate that by reducing chemoattractant-triggered release of
oxidative and proteolytic mediators from human PMNs, erythromycin may
have clinically useful antiinflammatory effects. (C) 1997 Elsevier Sci
ence Inc.